Miltefosine (MF), an alkyl phospholipid grown initially to treat breast tumor, is a highly effective situation for leishmaniasis, a neglected hot disease that is the planet's second leading cause of parasitic end of life after malaria.MF has lot-limiting gastrointestinal side effects in sufferers, and its infiltration through lipophilic barriers is lowered. This paper supplies an overview of the drug MF, its physicochemical features, pharmacokinetics, mechanism of action, and the differing nanocarriers used. It comprehensively reviews ultimate recent published essay on different methods for increasing the bioavailability of MF for the treatment of leishmaniasis. In current years, nanomedicine has emerged at the prominence of nanotechnology, creating high beliefs in the biomedical field. Researchers are developing novel nanoparticles for diagnostic requests using image technology and treatment requests using drug delivery sciences. Mesoporous silica nanoparticles (MSN), a porous material, have sparked interest on account of their appealing physicochemical properties and favorable morphological features.
Author(s) Details:
Parag Ghosh,
School
of Pharmacy, The Neotia University, Sarisa, West Bengal 743368, India.
Subhasish
Mondal,
School
of Pharmacy, The Neotia University, Sarisa, West Bengal 743368, India.
Anirbandeep Bose,
TAAB Biostudy Services, Kolkata, West Bengal, India.
Please see the link here: https://stm.bookpi.org/COPS-V4/article/view/9309
No comments:
Post a Comment